Search research articles
Contact Us
Filters
Showing results (171-180 of 241) with videos related to
Page
of 25
Sort By:
Therapeutic Advances in Medical Oncology
|
January 26, 2023
Identification of a large intra-exonic deletion in <i>BRCA2</i> exon 18 in a pancreatic ductal adenocarcinoma
Inès Debbabi, Sophie Vacher, Cindy Neuzillet, et al.
Neuroendocrinology
|
February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Louis de Mestier, Thomas Walter, Hedia Brixi, et al.
Pancreas
|
June 27, 2008
Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features
Olivier Corcos, Anne Couvelard, Sophie Giraud, et al.
Neuroendocrinology
|
August 21, 2019
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours
Anna Pellat, Thomas Walter, Jérémy Augustin, et al.
Gut
|
October 16, 2010
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
Laetitia Dahan, Frank Bonnetain, Marc Ychou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 29, 2008
Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study
Pierre-Emmanuel Rautou, Phillippe Lévy, Marie-Pierre Vullierme, et al.
Oncotarget
|
November 17, 2016
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
Stéphane Oudard, Reza Elaidi, Mara Brizard, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group
Clémence Breton, Antoine Meyer, David Malka, et al.
British Journal of Cancer
|
July 13, 2016
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 241) with videos related to
Sort By:
Page
of 25
Therapeutic Advances in Medical Oncology
|
January 26, 2023
Identification of a large intra-exonic deletion in <i>BRCA2</i> exon 18 in a pancreatic ductal adenocarcinoma
Inès Debbabi, Sophie Vacher, Cindy Neuzillet, et al.
Neuroendocrinology
|
February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Louis de Mestier, Thomas Walter, Hedia Brixi, et al.
Pancreas
|
June 27, 2008
Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features
Olivier Corcos, Anne Couvelard, Sophie Giraud, et al.
Neuroendocrinology
|
August 21, 2019
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours
Anna Pellat, Thomas Walter, Jérémy Augustin, et al.
Gut
|
October 16, 2010
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
Laetitia Dahan, Frank Bonnetain, Marc Ychou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 29, 2008
Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study
Pierre-Emmanuel Rautou, Phillippe Lévy, Marie-Pierre Vullierme, et al.
Oncotarget
|
November 17, 2016
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
Stéphane Oudard, Reza Elaidi, Mara Brizard, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group
Clémence Breton, Antoine Meyer, David Malka, et al.
British Journal of Cancer
|
July 13, 2016
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.
Page
of 25